Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
Novartis Pharmaceuticals Corporation and Novartis AG |
Mylan Pharmaceuticals Inc. |
1:2019cv00120 |
June 6, 2019 |
U.S. District Court for the Northern District of West Virginia |
Irene M Keeley |
Patent - Abbreviated New Drug Applications (ANDA) |
35 U.S.C. § 271 |
None |
Docket Report
This docket was last retrieved on June 11, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
![]() |
Filing 8 Pro Hac Vice Filing fee as to Nicholas N. Kallas: PAID $ 200.00, receipt number WVNC002628. (wrr) |
Filing 7 MOTION for Leave to Appear Pro Hac Vice of Nicholas N. Kallas by Novartis AG, Novartis Pharmaceuticals Corporation. (Attachments: #1 Text of Proposed Order)(Companion, James) |
Filing 6 VERIFICATION OF ATTORNEY ADMISSION.(sent via email) (jmm) |
Filing 5 Corporate Disclosure Statement by Novartis AG. (jmm) |
Filing 4 Corporate Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (jmm) |
Filing 3 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (jmm) |
Filing 2 Filing fee: $ 400.00, receipt number WVNW002198. (jmm) |
Filing 1 COMPLAINT against Mylan Pharmaceuticals Inc., filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: #1 Exhibit A Patent Number 5,665,772, #2 Exhibit B Patent Number US 8,778,962 B2, #3 Exhibit C Patent No. US 8,436,010 B2, #4 Suppleement Information for Patenet Cases Involving An Abbreviatd New Drug Appliation (ANDA), #5 Civil Cover Sheet)(jmm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.